Video

LAS VEGAS– Atopic dermatitis patients may be at increased risk for contact as well, Dr. Joseph Fowler said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

In an interview at the meeting, Dr. Fowler reviewed several emerging allergens, explained how contact dermatitis and atopic dermatitis interact, and shared some tips for identifying and managing both conditions when they occur simultaneously.

Dr. Fowler disclosed relationships with multiple pharmaceutical companies, none of which were relevant to the content of this video. SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

LAS VEGAS– Atopic dermatitis patients may be at increased risk for contact as well, Dr. Joseph Fowler said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

In an interview at the meeting, Dr. Fowler reviewed several emerging allergens, explained how contact dermatitis and atopic dermatitis interact, and shared some tips for identifying and managing both conditions when they occur simultaneously.

Dr. Fowler disclosed relationships with multiple pharmaceutical companies, none of which were relevant to the content of this video. SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

LAS VEGAS– Atopic dermatitis patients may be at increased risk for contact as well, Dr. Joseph Fowler said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

In an interview at the meeting, Dr. Fowler reviewed several emerging allergens, explained how contact dermatitis and atopic dermatitis interact, and shared some tips for identifying and managing both conditions when they occur simultaneously.

Dr. Fowler disclosed relationships with multiple pharmaceutical companies, none of which were relevant to the content of this video. SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

SAN FRANCISCO– Before attempting robotic surgery, it’s important to be comfortable with both the open and laparoscopic versions of the procedure, according to Dr. Kenneth Meredith, director of robotic surgery at the University of Wisconsin, Madison.

In experienced hands, robotic results can be good. In a case series of 138 robotic-assisted Ivor Lewis esophagectomies at the university for esophageal cancer, the median intensive care unit stay was 2 days and median hospital stay 9 days, Dr. Meredith. Complications occurred in about a quarter of patients.

In a video interview at the American College of Surgeons Clinical Congress, Dr. Meredith explained the significance of the findings and gave tips on how to negotiate the robotic surgery learning curve.

[email protected]

SAN FRANCISCO– Before attempting robotic surgery, it’s important to be comfortable with both the open and laparoscopic versions of the procedure, according to Dr. Kenneth Meredith, director of robotic surgery at the University of Wisconsin, Madison.

In experienced hands, robotic results can be good. In a case series of 138 robotic-assisted Ivor Lewis esophagectomies at the university for esophageal cancer, the median intensive care unit stay was 2 days and median hospital stay 9 days, Dr. Meredith. Complications occurred in about a quarter of patients.

In a video interview at the American College of Surgeons Clinical Congress, Dr. Meredith explained the significance of the findings and gave tips on how to negotiate the robotic surgery learning curve.

[email protected]

SAN FRANCISCO– Before attempting robotic surgery, it’s important to be comfortable with both the open and laparoscopic versions of the procedure, according to Dr. Kenneth Meredith, director of robotic surgery at the University of Wisconsin, Madison.

In experienced hands, robotic results can be good. In a case series of 138 robotic-assisted Ivor Lewis esophagectomies at the university for esophageal cancer, the median intensive care unit stay was 2 days and median hospital stay 9 days, Dr. Meredith. Complications occurred in about a quarter of patients.

In a video interview at the American College of Surgeons Clinical Congress, Dr. Meredith explained the significance of the findings and gave tips on how to negotiate the robotic surgery learning curve.

[email protected]

Managing a dermatology practice involves having a strong online presence that utilizes your practice's Web site and social media. Dr. Gary Goldenberg provides insight on creating content for your Web site, remaining HIPAA compliant, and keeping your social media posts relevant.

Managing a dermatology practice involves having a strong online presence that utilizes your practice's Web site and social media. Dr. Gary Goldenberg provides insight on creating content for your Web site, remaining HIPAA compliant, and keeping your social media posts relevant.

Managing a dermatology practice involves having a strong online presence that utilizes your practice's Web site and social media. Dr. Gary Goldenberg provides insight on creating content for your Web site, remaining HIPAA compliant, and keeping your social media posts relevant.

LAS VEGAS – The latest topical treatments “are going to change the way we treat onychomycosis,” Dr. David Pariser said at the Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

In an interview at the meeting, Dr. Pariser of Eastern Virginia Medical School, Norfolk, explained how the newly approved topical onychomycosis drugs work and shared some treatment strategies. Do they work even when patients are wearing nail polish? Tune in and find out.

SDEF and this news organization are owned by Frontline Medical Communications. Dr. Pariser has served as an investigator and consultant for Valeant and an investigator for Anacor.

[email protected]

LAS VEGAS – The latest topical treatments “are going to change the way we treat onychomycosis,” Dr. David Pariser said at the Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

In an interview at the meeting, Dr. Pariser of Eastern Virginia Medical School, Norfolk, explained how the newly approved topical onychomycosis drugs work and shared some treatment strategies. Do they work even when patients are wearing nail polish? Tune in and find out.

SDEF and this news organization are owned by Frontline Medical Communications. Dr. Pariser has served as an investigator and consultant for Valeant and an investigator for Anacor.

[email protected]

LAS VEGAS – The latest topical treatments “are going to change the way we treat onychomycosis,” Dr. David Pariser said at the Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

In an interview at the meeting, Dr. Pariser of Eastern Virginia Medical School, Norfolk, explained how the newly approved topical onychomycosis drugs work and shared some treatment strategies. Do they work even when patients are wearing nail polish? Tune in and find out.

SDEF and this news organization are owned by Frontline Medical Communications. Dr. Pariser has served as an investigator and consultant for Valeant and an investigator for Anacor.

[email protected]

HONOLULU– Uses for selective estrogen receptor modulators have grown beyond prevention of breast cancer or osteoporosis to treatment of postmenopausal symptoms.

Dr. Cynthia Stuenkel spoke about selective estrogen receptor modifiers (SERMs) and menopause in a keynote address at the annual meeting of the American Society for Reproductive Medicine.

In a video interview, Dr. Stuenkel talks about two of the newer SERM options – ospemifene for dyspareunia and a combination of the SERM bazedoxifene and conjugated equine estrogens that’s available outside of the United States to treat vasomotor symptoms or for prevention of bone loss.

These new tools expand clinical options – but, as with any new therapy – longer and larger studies of the newer agents are needed to more carefully assess long-term safety, said Dr. Stuenkel of the University of California, San Diego.

She reported having no financial disclosures.

[email protected]

On Twitter @sherryboschert

HONOLULU– Uses for selective estrogen receptor modulators have grown beyond prevention of breast cancer or osteoporosis to treatment of postmenopausal symptoms.

Dr. Cynthia Stuenkel spoke about selective estrogen receptor modifiers (SERMs) and menopause in a keynote address at the annual meeting of the American Society for Reproductive Medicine.

In a video interview, Dr. Stuenkel talks about two of the newer SERM options – ospemifene for dyspareunia and a combination of the SERM bazedoxifene and conjugated equine estrogens that’s available outside of the United States to treat vasomotor symptoms or for prevention of bone loss.

These new tools expand clinical options – but, as with any new therapy – longer and larger studies of the newer agents are needed to more carefully assess long-term safety, said Dr. Stuenkel of the University of California, San Diego.

She reported having no financial disclosures.

[email protected]

On Twitter @sherryboschert

HONOLULU– Uses for selective estrogen receptor modulators have grown beyond prevention of breast cancer or osteoporosis to treatment of postmenopausal symptoms.

Dr. Cynthia Stuenkel spoke about selective estrogen receptor modifiers (SERMs) and menopause in a keynote address at the annual meeting of the American Society for Reproductive Medicine.

In a video interview, Dr. Stuenkel talks about two of the newer SERM options – ospemifene for dyspareunia and a combination of the SERM bazedoxifene and conjugated equine estrogens that’s available outside of the United States to treat vasomotor symptoms or for prevention of bone loss.

These new tools expand clinical options – but, as with any new therapy – longer and larger studies of the newer agents are needed to more carefully assess long-term safety, said Dr. Stuenkel of the University of California, San Diego.

She reported having no financial disclosures.

[email protected]

On Twitter @sherryboschert